{"entity":{"type":"insider","cik":"0001667937","url":"/insider/0001667937","json_url":"/insider/0001667937.json","name":"Ali Faraz","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":19,"n_filings":10,"first":"2023-08-18","last":"2026-08-17","span_basis":"filed_date"},"name_variants":[{"name":"Ali Faraz","source":"filing","n_filings":10,"first_seen":"2023-08-18","last_seen":"2026-08-17"}],"transactions":[{"id":9255839,"accession":"0001193125-26-354518","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-354518","line_url":"/filing/0001193125-26-354518","is_derivative":false,"issuer_cik":"0001667937","issuer_name":"Tenaya Therapeutics, Inc.","issuer_ticker":"TNYA","issuer_name_source":null,"issuer_url":"/issuer/0001667937","owner_cik":"0001667937","owner_name":"Ali Faraz","owner_display_name":"Ali Faraz","owner_url":"/insider/0001667937","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22232.0,"shares_display":"22,232","price_per_share":0.7097178526448362,"price_display":"0.71","price_state":"stated","total_value":15778.4473,"total_display":"15,778.45","total_whole":"15,778","shares_owned_after":434177.0,"shares_owned_after_display":"434,177","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-17","filed_date":"2026-08-17","scope":"insider","n_lines":4},{"id":5907665,"accession":"0001193125-26-231324","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-231324","line_url":"/filing/0001193125-26-231324#line-1","is_derivative":false,"issuer_cik":"0001667937","issuer_name":"Tenaya Therapeutics, Inc.","issuer_ticker":"TNYA","issuer_name_source":null,"issuer_url":"/issuer/0001667937","owner_cik":"0001667937","owner_name":"Ali Faraz","owner_display_name":"Ali Faraz","owner_url":"/insider/0001667937","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3390.0,"shares_display":"3,390","price_per_share":0.7934,"price_display":"0.79","price_state":"stated","total_value":2689.626,"total_display":"2,689.63","total_whole":"2,690","shares_owned_after":440014.0,"shares_owned_after_display":"440,014","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-18","filed_date":"2026-05-19","scope":"insider"},{"id":6087367,"accession":"0001193125-26-055442","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-26-055442","line_url":"/filing/0001193125-26-055442","is_derivative":false,"issuer_cik":"0001667937","issuer_name":"Tenaya Therapeutics, Inc.","issuer_ticker":"TNYA","issuer_name_source":null,"issuer_url":"/issuer/0001667937","owner_cik":"0001667937","owner_name":"Ali Faraz","owner_display_name":"Ali Faraz","owner_url":"/insider/0001667937","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14862.0,"shares_display":"14,862","price_per_share":0.6430267729780649,"price_display":"0.64","price_state":"stated","total_value":9556.6639,"total_display":"9,556.66","total_whole":"9,557","shares_owned_after":452415.0,"shares_owned_after_display":"452,415","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-17","filed_date":"2026-02-17","scope":"insider","n_lines":3},{"id":4755272,"accession":"0001193125-25-284996","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-284996","line_url":"/filing/0001193125-25-284996#line-1","is_derivative":false,"issuer_cik":"0001667937","issuer_name":"Tenaya Therapeutics, Inc.","issuer_ticker":"TNYA","issuer_name_source":null,"issuer_url":"/issuer/0001667937","owner_cik":"0001667937","owner_name":"Ali Faraz","owner_display_name":"Ali Faraz","owner_url":"/insider/0001667937","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3126.0,"shares_display":"3,126","price_per_share":1.33,"price_display":"1.33","price_state":"stated","total_value":4157.58,"total_display":"4,157.58","total_whole":"4,158","shares_owned_after":299666.0,"shares_owned_after_display":"299,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-17","filed_date":"2025-11-17","scope":"insider"},{"id":4479462,"accession":"0001667937-25-000006","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001667937-25-000006","line_url":"/filing/0001667937-25-000006","is_derivative":false,"issuer_cik":"0001667937","issuer_name":"Tenaya Therapeutics, Inc.","issuer_ticker":"TNYA","issuer_name_source":null,"issuer_url":"/issuer/0001667937","owner_cik":"0001667937","owner_name":"Ali Faraz","owner_display_name":"Ali Faraz","owner_url":"/insider/0001667937","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14533.0,"shares_display":"14,533","price_per_share":1.253,"price_display":"1.25","price_state":"stated","total_value":18209.849,"total_display":"18,209.85","total_whole":"18,210","shares_owned_after":311605.0,"shares_owned_after_display":"311,605","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-18","filed_date":"2025-08-18","scope":"insider","n_lines":3},{"id":4496280,"accession":"0000950170-25-073823","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-073823","line_url":"/filing/0000950170-25-073823#line-1","is_derivative":false,"issuer_cik":"0001667937","issuer_name":"Tenaya Therapeutics, Inc.","issuer_ticker":"TNYA","issuer_name_source":null,"issuer_url":"/issuer/0001667937","owner_cik":"0001667937","owner_name":"Ali Faraz","owner_display_name":"Ali Faraz","owner_url":"/insider/0001667937","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3189.0,"shares_display":"3,189","price_per_share":0.4427,"price_display":"0.44","price_state":"stated","total_value":1411.7703,"total_display":"1,411.77","total_whole":"1,412","shares_owned_after":317325.0,"shares_owned_after_display":"317,325","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-16","filed_date":"2025-05-16","scope":"insider"},{"id":5157519,"accession":"0000950170-25-036770","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-036770","line_url":"/filing/0000950170-25-036770","is_derivative":false,"issuer_cik":"0001667937","issuer_name":"Tenaya Therapeutics, Inc.","issuer_ticker":"TNYA","issuer_name_source":null,"issuer_url":"/issuer/0001667937","owner_cik":"0001667937","owner_name":"Ali Faraz","owner_display_name":"Ali Faraz","owner_url":"/insider/0001667937","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9741.0,"shares_display":"9,741","price_per_share":0.5384,"price_display":"0.54","price_state":"stated","total_value":5244.5544,"total_display":"5,244.55","total_whole":"5,245","shares_owned_after":324461.0,"shares_owned_after_display":"324,461","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-10","filed_date":"2025-03-10","scope":"insider","n_lines":2},{"id":2237661,"accession":"0000950170-24-098234","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-098234","line_url":"/filing/0000950170-24-098234","is_derivative":false,"issuer_cik":"0001667937","issuer_name":"Tenaya Therapeutics, Inc.","issuer_ticker":"TNYA","issuer_name_source":null,"issuer_url":"/issuer/0001667937","owner_cik":"0001667937","owner_name":"Ali Faraz","owner_display_name":"Ali Faraz","owner_url":"/insider/0001667937","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9748.0,"shares_display":"9,748","price_per_share":2.8945,"price_display":"2.89","price_state":"stated","total_value":28215.586,"total_display":"28,215.59","total_whole":"28,216","shares_owned_after":192277.0,"shares_owned_after_display":"192,277","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-16","filed_date":"2024-08-16","scope":"insider","n_lines":2},{"id":2824461,"accession":"0000950170-24-016664","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-016664","line_url":"/filing/0000950170-24-016664#line-1","is_derivative":false,"issuer_cik":"0001667937","issuer_name":"Tenaya Therapeutics, Inc.","issuer_ticker":"TNYA","issuer_name_source":null,"issuer_url":"/issuer/0001667937","owner_cik":"0001667937","owner_name":"Ali Faraz","owner_display_name":"Ali Faraz","owner_url":"/insider/0001667937","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6358.0,"shares_display":"6,358","price_per_share":5.86,"price_display":"5.86","price_state":"stated","total_value":37257.88,"total_display":"37,257.88","total_whole":"37,258","shares_owned_after":113079.0,"shares_owned_after_display":"113,079","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-16","filed_date":"2024-02-16","scope":"insider"},{"id":7836308,"accession":"0001209191-23-046639","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-046639","line_url":"/filing/0001209191-23-046639#line-1","is_derivative":false,"issuer_cik":"0001667937","issuer_name":"Tenaya Therapeutics, Inc.","issuer_ticker":"TNYA","issuer_name_source":null,"issuer_url":"/issuer/0001667937","owner_cik":"0001667937","owner_name":"Ali Faraz","owner_display_name":"Ali Faraz","owner_url":"/insider/0001667937","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5563.0,"shares_display":"5,563","price_per_share":3.81,"price_display":"3.81","price_state":"stated","total_value":21195.03,"total_display":"21,195.03","total_whole":"21,195","shares_owned_after":119437.0,"shares_owned_after_display":"119,437","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-16","filed_date":"2023-08-18","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":19,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":19,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":19},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001858848","name":"Tenaya Therapeutics, Inc.","url":"/issuer/0001858848","role":"Director, Officer (Chief Executive Officer)","n_filings":10,"first_seen":"2023-08-18","last_seen":"2026-08-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001667937","retrieved_at":"2026-08-25T19:59:16+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}